Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity
Open Access
- 24 June 2020
- journal article
- research article
- Published by American Society for Microbiology in mSphere
- Vol. 5 (3)
Abstract
In humans, nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease due to the increased prevalence of obesity. While treatment of NAFLD is often geared toward lifestyle changes, such as diet and exercise, the use of dietary supplements such as probiotics is underinvestigated. Here, we report that probioticLactobacillus reuterireduces fatty liver in a mouse model of diet-induced obesity. This phenotype was further enhanced upon delivery of recombinant interleukin-22 by engineeredLactobacillus reuteri. These observations pave the road to a better understanding of probiotic mechanisms driving the reduction of diet-induced steatosis and to development of next-generation probiotics for use in the clinic. Ultimately, these studies may lead to rational selection of (engineered) probiotics to ameliorate fatty liver disease.Keywords
Funding Information
- Food Research Institute (233PRJ75PW)
- UW-Madison Graduate School (135AAA2218)
- UW-Madison ICTR funded by Natl. Center for Advancing Translational Science (UL1TR000427)
- U.S. Department of Agriculture (2018-6717-27523)
This publication has 25 references indexed in Scilit:
- A review on the strategies for oral delivery of proteins and peptides and their clinical perspectivesSaudi Pharmaceutical Journal, 2016
- Switch over from intravenous to oral therapy: A concise overviewJournal of Pharmacology and Pharmacotherapeutics, 2014
- Role of Interleukin-22 in liver diseasesInflammation Research, 2014
- Rapid and Reliable DNA Assembly via Ligase Cycling ReactionACS Synthetic Biology, 2014
- Histamine Derived from Probiotic Lactobacillus reuteri Suppresses TNF via Modulation of PKA and ERK SignalingPLOS ONE, 2012
- Interleukin-22 Forms Dimers that are Recognized by Two Interleukin-22R1 Receptor ChainsBiophysical Journal, 2008
- A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2006
- Definition of Metabolic SyndromeCirculation, 2004
- Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCRNucleic Acids Research, 2002
- Transformation ofLactobacillus reuteri with electroporation: Studies on the erythromycin resistance plasmid pLUL631Current Microbiology, 1992